Richard Bleicher, MD
Surgical Oncology · Philadelphia, PANPI 1275584609
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Elucent Medical accounts for 98.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $26,112 and has fallen 97.6% since, to $635 in 2025. Among surgical oncology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $1069.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elucent Medical$52K
- KUB Technologies Inc.$495
- Endomagnetics Ltd$224
- Daiichi Sankyo Inc.$105
- Eisai Inc.$104
- Merit Medical Systems Inc$100
- plus $14 from 1 others
What the payments were for
- Consulting fees$25,97549%
- Speaking & faculty fees$19,00036%
- Travel & lodging$4,6029%
- Food & beverage$3,7047%
- Entertainment$1910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elucent Medical | 40 | $52,430 |
| KUB Technologies Inc. | 3 | $495 |
| Endomagnetics Ltd | 2 | $224 |
| Daiichi Sankyo Inc. | 2 | $105 |
| Eisai Inc. | 1 | $104 |
| Merit Medical Systems Inc | 1 | $100 |
| Tersera Therapeutics LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mozart$495
- Magseed$182
- Magtrace$182
- Savi SCOUT$100
How this compares
$53,472 in reported general payments places this provider in the 95th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Philadelphia
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- Mark EtheringtonPhiladelphia$6K
- Anthony VillanoPhiladelphia$4K
- Stephanie GrecoPhiladelphia$3K
- James SunPhiladelphia$3K
- John RidgePhiladelphia$3K
- Steven StandifordPhiladelphia$487
- Alliric WillisPhiladelphia$254
- Jennifer ZhangPhiladelphia$200
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.